Get in Touch

Learn more about reaching providers at the point of care, within the #1 medical reference app. Submit your information and we’ll be in touch soon.


Engage health care providers in the moments of care

Epocrates embeds your brand messages at multiple points across the care continuum, inside the clinical workflow, when doctors are most open and receptive. Explore our unique solutions for reaching the right provider at the right time.

Insights & resources

Webinars, reports and more on making meaningful connections with physicians.

  • Medical App

    DRG “Taking the Pulse” ®
    U.S. Physicians Survey
  • "3x more daily sessions than competitors"

    Kantar Media
    Non-Journal Media, 2017
  • Prescribers’ #1 source for dosing, efficacy and safety information

    DRG “Taking the Pulse” ®
    U.S. Physicians Survey

DocAlert messages

Send concise, branded clinical content targeted by disease state, occupation, specialty, look-up behavior, formulary coverage, geographies or target match. DocAlerts now feature enhanced reporting, including physician-level data, and are proven to influence providers in the moments of care—3:1 ROI and higher confirmed by 10 out of 10 recent studies.

2 in 3 physicians share a DocAlert
with a colleague

Infographic: How DocAlerts Engage Prescribers in the Moments of Care

Home Screen Messaging

Create instant awareness among targeted specialties and occupations with exclusive positioning on the Epocrates home screen.

Monograph Messaging

Reach providers when they're actively searching for product information. These actionable brand messages are surfaced within Rx and OTC drug monograph, with flexible messaging and targeting.

"Epocrates helps me make the best medication choices for my patients."

Laurel Williston, MD,
Family Practice

View HCP Research

HCP Research

Access the nation's largest verified and opted-in physician panel. Use this self-service tool to learn more about provider trends and opinions, gauge brand awareness and assess the impact of your campaign.